Health
Report: Moderna Sets Price Range for Coronavirus Vaccine – Motley Fool
If and when mRNA-1273 becomes available, it will apparently be relatively expensive.
Considered by many observers to be the leader in the hunt for a coronavirus vaccine, Moderna(NASDAQ:MRNA) has apparently settled on a price for its potential blockbuster product. Citing “people familiar with talks between the company and potential buyers,” the Financial Times reported Tuesday that the company aims to sell its vaccine at roughly $50 to $60 per two-dose treatment course.
That price applies to relatively prosperous countries such as the U.S. The article quoted “other people famili…
-
General8 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General11 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
General19 hours agoNewsCorp executive warns AI firms are asking Australia to ‘surrender our stories’
-
General23 hours agoTrio of scientists win Nobel Prize in Chemistry for ‘development of metal-organic frameworks’